Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder
Xiaoming Wang,* Yunjin Bai,* Facai Zhang, Yubo Yang, Dechao Feng, Ao Li, Zhiqiang Yang, Dengxiong Li, Yin Tang, Xin Wei, Wuran Wei, Ping Han Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, People’s Republic of China*The...
Main Authors: | Wang X, Bai Y, Zhang F, Yang Y, Feng D, Li A, Yang Z, Li D, Tang Y, Wei X, Wei W, Han P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/targeted-inhibition-of-p4hb-promotes-cell-sensitivity-to-gemcitabine-i-peer-reviewed-article-OTT |
Similar Items
-
COMPARISON BETWEEN GEMCITABINE-CARBOPLATIN AND COMBINATION OF GEMCITABINE-CARBOPLATIN AND CELECOXIB IN UROTHELIAL CARCINOMA CELL APOPTOSIS
by: Widya Sakti Pratama, et al.
Published: (2019-01-01) -
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
by: Daniel Herchenhorn, et al.
Published: (2007-10-01) -
Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
by: Marco Massafra, et al.
Published: (2021-01-01) -
Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
by: Rongxin Li, et al.
Published: (2020-07-01) -
RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy
by: Zhenxing Yang, et al.
Published: (2019-07-01)